TXG
10X Genomics Inc
80.70$
+2.0%
vs. previous close
Closing price · As of: Sep 22, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| -15.1% | -52.2% | 14.1% | -72.9% | -4.4% | -6.5% | -2.5% | 1.1% | 21.2% | |
| 6.1% | 2.7% | 2.9% | 6.4% | 5.8% | 6.4% | 7.0% | 7.2% | 6.8% | |
| 2.3% | 1.8% | 5.4% | 16.3% | 19.6% | 26.5% | 27.0% | 23.0% | 17.0% | |
| 2.3% | 2.5% | 5.7% | 119.2% | 19.6% | 26.7% | – | – | – | |
| 2.7% | 19.1% | 18.2% | -16.9% | -17.8% | -7.6% | 2.8% | 0.2% | 3.9% | |
| 5.3% | 4.6% | 17.4% | 12.8% | 20.6% | 25.5% | 8.0% | 2.0% | 0.9% | |
| -5.3% | -4.6% | -17.4% | -12.8% | -21.8% | -67.9% | 21.6% | -5.3% | -2.1% | |
| 0.0% | 0.0% | – | – | – | – | – | – | – | |
| -0.1% | 0.0% | 0.0% | 169.3% | 8.2% | 4.1% | – | – | – | |
| -0.6% | 12.8% | -15.1% | -12.4% | -1.0% | -1.0% | – | – | – | |
| 29.0% | 72.0% | 168.6% | 156.9% | 7.2% | 3.1% | 2.2% | 1.8% | 1.1% | |
| 8.6% | 15.2% | 165.3% | 71.0% | -18.9% | -71.4% | 21.3% | -2.5% | 20.2% | |
| -20.3% | -56.8% | -3.3% | -85.8% | -25.0% | -32.0% | -10.5% | -0.9% | 20.2% |
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.